It was further shown that bisphosphonates inhibit the vascular endothelial growth factor (VEGF)-mediated angiogenesis of breast cancer cells via suppression of the IGF-1/AKT/HIF-1α/VEGF axis [97]. The gene discussed is AKT1; the disease is breast carcinoma.